HVC
FOLD

Healthcare Value Capital’s Amicus Therapeutics FOLD Stock Holding History

Healthcare Value Capital’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-200,000
Closed -$414K – 36
2014
Q1 		$414K Sell
200,000
-50,000
-20% -$125K 0.27% 41
2013
Q4 		$588K Buy
250,000
+115,000
+85% +$252K 0.43% 29
2013
Q3 		$313K Buy
+135,000
New +$339K 0.27% 46

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SEP
Sound Energy Partners Greenwich, Connecticut $49.5M AUM 35.64% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Healthcare Value Capital's FOLD Position: Q2 2014 in Review

Healthcare Value Capital sold out of Amicus Therapeutics (FOLD) in Q2 2014, closing a stake of 200,000 shares — an estimated $414K sold.

Healthcare Value Capital first reported a position in FOLD in Q3 2013 and held it in 3 quarters. The position peaked at $588K in Q4 2013. 60 funds tracked by Wall St. Rank hold FOLD as of Q2 2014.

  • Healthcare Value Capital reported no remaining Amicus Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Healthcare Value Capital sold 200,000 Amicus Therapeutics shares in Q2 2014, an estimated $414K.
  • Healthcare Value Capital first reported a position in Amicus Therapeutics in Q3 2013 and held it in 3 quarters.
  • Healthcare Value Capital's Amicus Therapeutics position peaked at $588K in Q4 2013.
  • 60 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2014.

Based on Healthcare Value Capital's 13F filing for Q2 2014, filed 13 Aug 2014.